Stuttgart - Delayed Quote EUR

IDEAYA Biosciences, Inc. (30J.SG)

Compare
23.20
+0.80
+(3.57%)
At close: January 31 at 9:34:14 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,922.00
23,385.00
50,931.00
27,941.00
19,538.00
Operating Expense
228,676.00
157,814.00
113,433.00
78,209.00
54,882.00
Operating Income
-224,754.00
-134,429.00
-62,502.00
-50,268.00
-35,344.00
Net Non Operating Interest Income Expense
46,634.00
21,468.00
3,847.00
506.00
849.00
Pretax Income
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Net Income Common Stockholders
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Diluted NI Available to Com Stockholders
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Basic EPS
-2.33
-1.96
-1.42
-1.41
-1.40
Diluted EPS
-2.33
-1.96
-1.42
-1.41
-1.40
Basic Average Shares
76,165.36
57,519.93
41,444.70
35,252.44
24,721.78
Diluted Average Shares
76,165.36
57,519.93
41,444.70
35,252.44
24,721.78
Total Operating Income as Reported
-224,754.00
-134,429.00
-62,502.00
-50,268.00
-35,344.00
Total Expenses
228,676.00
157,814.00
113,433.00
78,209.00
54,882.00
Net Income from Continuing & Discontinued Operation
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Normalized Income
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Interest Income
46,634.00
21,468.00
3,847.00
506.00
849.00
Net Interest Income
46,634.00
21,468.00
3,847.00
506.00
849.00
EBIT
-224,754.00
-134,429.00
-62,502.00
-50,268.00
-35,344.00
EBITDA
-220,539.00
-130,421.00
-58,987.00
-47,236.00
-33,963.00
Reconciled Depreciation
4,215.00
4,008.00
3,515.00
3,032.00
1,381.00
Net Income from Continuing Operation Net Minority Interest
-178,120.00
-112,961.00
-58,655.00
-49,762.00
-34,495.00
Normalized EBITDA
-220,539.00
-130,421.00
-58,987.00
-47,236.00
-33,963.00
12/31/2020 - 6/12/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SER Serina Therapeutics, Inc.
4.7000
+2.17%
 
AADI Aadi Bioscience, Inc.
2.8800
0.00%
 
CELC Celcuity Inc.
11.95
+1.96%
 
THTX Theratechnologies Inc.
1.4400
+0.70%
 
APGE Apogee Therapeutics, Inc.
41.36
-2.68%
 
VRDN Viridian Therapeutics, Inc.
19.38
-3.49%
 
ADCT ADC Therapeutics SA
1.6800
-2.33%
 
CRNX Crinetics Pharmaceuticals, Inc.
40.30
+0.10%
 
OVID Ovid Therapeutics Inc.
0.6634
-5.24%
 
COGT Cogent Biosciences, Inc.
9.31
-3.22%